不明来源栓塞性卒中的心源性栓塞风险分层方法
本文综述不明来源栓塞性卒中(ESUS)患者中识别心源性栓塞高风险亚组的现有证据,提出基于心律失常监测、心脏影像和临床风险分层的策略,以指导抗凝治疗选择。该方法可能改善患者预后并减少卒中复发,但需进一步试验验证。
要点
- ESUS指充分检查后未确认病因的非腔隙性缺血性卒中,推测栓塞机制。
- 经验性抗凝可能仅对心源性栓塞亚组有益,需风险分层识别。
- 基于心律失常监测、心脏影像和临床风险的分层策略正在研究中。
核心结论
- 经验性抗凝对ESUS患者可能仅对心源性栓塞亚组有益,需风险分层识别该亚组。
研究设计与样本
- 综述,检索范围未明确报告。
主要发现
- 基于心律失常监测、心脏影像和临床风险分层的策略可能有助于识别心源性栓塞高风险ESUS患者。
临床怎么用
- 临床可考虑基于心律失常监测、心脏影像和临床风险分层来识别可能从抗凝中获益的ESUS患者。
局限性
- 需进一步研究验证,相关试验正在进行中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ischemic stroke is a leading cause of morbidity and mortality worldwide. Embolic stroke of undetermined source has been recently proposed to categorize nonlacunar ischemic strokes without confirmed etiology after adequate investigation with a likely embolic stroke mechanism. A strategy of empirical anticoagulation for embolic stroke of undetermined source patients is attractive but may only be beneficial in a select subset of patients. Strategies which would help identify the subset of embolic stroke of undetermined source patients most likely to have cardioembolic origin of stroke, and hence benefit from anticoagulation, are needed. This article will review current evidence which may be useful in the development of a risk stratification approach based on arrhythmia monitoring, cardiac imaging, and clinical risk stratification. This approach may be beneficial in clinical practice in improving patient outcomes and reducing stroke recurrence in this population; however, further work is required with active trials underway.
引用
- Bhat A, Mahajan V, Chen HHL, et al. Embolic Stroke of Undetermined Source: Approaches in Risk Stratification for Cardioembolism. Stroke. 2021. PMID: 34706562. doi:10.1161/STROKEAHA.121.034498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。